(Phe1-(R)-Gly2)-Nociceptin (1-13) amide incorporates a stereospecific glycine modification that influences chain orientation and ligand-receptor topology. The substitution alters flexibility and supports analysis of nociceptin signaling cores. Its structural features help reveal determinants of opioid-like peptide recognition. Researchers use it in mapping functional regions responsible for receptor activation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More